Dr. Kirsten Haas
Dr. phil. Kirsten Haas
Josef-Schneider-Str. 2 / Haus D7
Telefon:
+49 931-201 47302
Fax:
+49 931-201 647310
E-Mail:
Kirsten.Haas@uni-wuerzburg.de
kurzer Lebenslauf
2014 | Promotion zur Dr. phil. (magna cum laude), TU Dortmund |
seit 2013 | Wissenschaftliche Mitarbeiterin, Institut für Klinische Epidemiologie und Biometrie, Universität Würzburg |
2009-2013 | Wissenschaftliche Mitarbeiterin, Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Arbeitsgruppe "Mentale Gesundheit und Kognitive Leistungsfähigkeit", Berlin |
2000-2008 | Leiterin Qualitätsmanagement QuaSi-Niere gGmbH, Berlin |
1999-2000 | Wissenschaftliche Mitarbeiterin TU Chemnitz, Leiterin Forschungsstelle für Regionale Gesundheitsförderung, Chemnitz |
1998-1999 | freie wissenschaftliche Mitarbeiterin Bundesgesundheitssurvey 1998, Robert-Koch-Institut, Berlin |
1995-1998 | Postgraduiertenstudiengang "Public Health", TU Berlin, Abschluss MPH |
1987-1993 | Studium Ökotrophologie, Fachrichtung Ernährungswissenschaften, Christian-Albrechts-Universität Kiel, Abschluss Diplom |
wissenschaftliche Schwerpunkte
Registerarbeit, Qualitätsmanagement, Evaluation
Hauptpublikationen der letzten Jahre
2024[ to top ]
-
Development and pilot-testing of an evidence-based quality indicator set for home mechanical ventilation care: the OVER-BEAS project. BMC Health Services Research [Internet]. 2024;24(1):152. Available from: https://doi.org/10.1186/s12913-024-10583-2.
- [ DOI ]
-
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial. Trials [Internet]. 2024;25(1):767. Available from: https://doi.org/10.1186/s13063-024-08614-8.
- [ DOI ]
2023[ to top ]
-
Die notärztliche Versorgung von langzeitbeatmeten Patienten im außerstationären Umfeld – im Spannungsfeld zwischen Intensivmedizin und häuslicher Versorgung. NOTARZT. 2023;..
- [ DOI ]
-
Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany. BMC Med Ethics. 2023;24(1):84..
- [ DOI ]
-
Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design. EClinicalMedicine. 2023;65:102260..
- [ DOI ]
-
[Analysis of the weaning process in intensive care patients with regard to documentation and transfer to further treatment units]. Med Klin Intensivmed Notfmed. 2023;118(4):269-76..
- [ DOI ]
-
[Complexity of outpatient intensive care for ventilated people: Cross-mapping into the standardised NNN-taxonomy]. Pflege. 2023;36(5):259-68..
- [ DOI ]
-
Systematic review with meta-analysis: Stress-management interventions for patients with irritable bowel syndrome. Stress Health. 2023;..
- [ DOI ]
-
Prospective single-center study of health-related quality of life after COVID-19 in ICU and non-ICU patients. Sci Rep. 2023;13(1):6785..
- [ DOI ]
2022[ to top ]
-
Komplexität außerstationärer Intensivpflege beatmeter Menschen [Complexity of outpatient intensive care for ventilated people: Cross-mapping into the standardised NNN-taxonomy]. Pflege [Internet]. 2022;:null. Available from: https://econtent.hogrefe.com/doi/abs/10.1024/1012-5302/a000919.
- [ DOI ]
-
Comparing the quality of care for long-term ventilated individuals at home versus in shared living communities: a convergent parallel mixed-methods study. BMC Nursing [Internet]. 2022;21(1):224. Available from: https://doi.org/10.1186/s12912-022-00986-z.
- [ DOI ]
-
Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):190..
- [ DOI ]
-
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study. Orphanet Journal of Rare Diseases [Internet]. 2022;17(1):47. Available from: https://doi.org/10.1186/s13023-022-02176-1.
- [ DOI ]
-
1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP). Open Forum Infectious Diseases [Internet]. 2022;9(Supplement_2). Available from: https://doi.org/10.1093/ofid/ofac492.1513.
- [ DOI ]
-
Analyse des Weaningprozesses bei Intensivpatienten im Hinblick auf Dokumentation und Verlegung in weiterbehandelnde Einheiten [Analysis of the weaning process in intensive care patients with regard to documentation and transfer to further treatment units]. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2022;118..
- [ DOI ]
-
Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. Stroke. 2022;53(8):2559-68..
- [ DOI ]
2021[ to top ]
-
[Ventilation Patients between Acute Care and Long-term Out-of-Hospital Ventilation - Routine Documentation based Analysis of the Care Situation]. Pneumologie. 2021;..
- [ DOI ]
-
How to improve the quality of care for people on home mechanical ventilation from the perspective of healthcare professionals: a qualitative study. BMC Health Services Research [Internet]. 2021;21(1):774. Available from: https://doi.org/10.1186/s12913-021-06743-3.
- [ DOI ]
-
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8..
- [ DOI ]
2020[ to top ]
-
Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry. Pilot and Feasibility Studies [Internet]. 2020;6(1):11. Available from: https://doi.org/10.1186/s40814-019-0541-3.
- [ DOI ]
-
Versorgung von Parkinson-Patienten in Deutschland. Der Nervenarzt [Internet]. 2020;91(6):493-502. Available from: https://doi.org/10.1007/s00115-020-00890-4.
- [ DOI ]
-
Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke. Stroke [Internet]. 2020;51(12):3664-72. Available from: https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.120.029968.
- [ DOI ]
2019[ to top ]
-
Role of B cells in chronic graft-versus-host disease after allogeneic stem cell transplantation in children and adolescents. Br J Haematol. 2019;186(5):e133-e137..
- [ DOI ]
-
Rationale and design of the Registry of Acute Stroke Under Novel Oral Anticoagulants-prime (RASUNOA-prime). Eur Stroke J. 2019;4(2):181-8..
- [ DOI ]
-
Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson’s disease and first year experience of implementation of a nation-wide registry. Parkinsonism & Related Disorders [Internet]. 2019;60:3-9. Available from: https://www.sciencedirect.com/science/article/pii/S1353802019300161.
- [ DOI ]
2018[ to top ]
-
Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants. Acta Neurol Scand. 2018;138(2):163-9..
- [ DOI ]
2017[ to top ]
-
Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants. J Stroke. 2017;19(1):67-76..
- [ DOI ]
-
Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants. Neurocrit Care. 2017;27(2):208-13..
- [ DOI ]
-
Risk-adjusted procedure tailoring leads to uniformly low complication rates in ventral and incisional hernia repair: a propensity score analysis and internal validation of classification criteria. Hernia. 2017;21(4):569-82..
- [ DOI ]
2016[ to top ]
-
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants. JAMA Neurol. 2016;73(2):169-77..
- [ DOI ]
-
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. Stroke. 2016;47(4):1127-30..
- [ DOI ]
-
Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants. Stroke. 2016;48(1):152-8..
- [ DOI ]